Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-021677)

Filing Details

Accession Number:: 0001181431-10-021677
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-15 13:00:00
Reporting Period:: 2010-04-13

Filing Date:: 2010-04-15
Accepted Time:: 2010-04-15 13:23:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1278709	Dino Dina	C/O Dynavax Technologies Corporation 2929 Seventh Street, Suite 100 Berkeley CA 94710	President, Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-13	70,000	$0.00	70,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (Right to Buy)	Acquisiton	2010-04-13	35,000	$0.00	35,000	$1.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
35,000	2010-04-16	2015-04-16	No	4	P	Direct

Footnotes

The reported securities are included within 70,000 Units purchased by the reporting person for $1.4525 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.5 share of common stock.